Mes: mayo 2020

POSaBIT Inc. Provides Update on Release of Annual Financial Statements and Related Disclosures for Fiscal Year 2019 Related Disclosures

SEATTLE--(BUSINESS WIRE)--POSaBIT Inc. (CSE:PBIT) announces an update on the filing of its Annual Financial Statements and related Disclosures (the “Annual Disclosures”) for the year ended December 31, 2019. The Company is continuing to work diligently and expeditiously with its auditors, and anticipates that the Annual Disclosures will be filed by…
Leer más...
GSE Solutions Provides Update on Form 10-K Filing

GSE Solutions Provides Update on Form 10-K Filing

COLUMBIA, Md.--(BUSINESS WIRE)--GSE Systems, Inc. (“GSE Solutions”, “GSE”, or “the Company”) (Nasdaq: GVP), a leader in delivering and supporting end-to-end training, engineering, compliance, simulation, and workforce solutions to the power industry, today announced that, due to circumstances primarily stemming from the COVID-19 pandemic, the Company will not timely file its…
Leer más...
Molina Healthcare Wins Kentucky Medicaid Contract

Molina Healthcare Wins Kentucky Medicaid Contract

LONG BEACH, Calif.--(BUSINESS WIRE)--$MOH--Molina Healthcare, Inc. (NYSE: MOH) today announced that its Kentucky health plan subsidiary has been selected as an awardee pursuant to the statewide Medicaid managed care RFP issued on January 10, 2020 by the Kentucky Cabinet for Health and Family Services (CHFS), Department for Medicaid Services (DMS).…
Leer más...
Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Phase 2 study expected to enroll 600 participants Finalizing protocol for Phase 3 study, expected to begin in July 2020 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced…
Leer más...
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of iQIYI, Inc. Investors (IQ)

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of iQIYI, Inc. Investors (IQ)

LOS ANGELES--(BUSINESS WIRE)--$IQ #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired iQIYI, Inc. ("iQIYI" or the Company") (NASDAQ: IQ) securities between March 29, 2018 and April 7, 2020, inclusive (the “Class…
Leer más...

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Reminds Zoom Video Communications, Inc. Investors of Important June 8 Deadline in Securities Class Action – ZM

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zoom Video Communications, Inc. (NASDAQ: ZM) between April 18, 2019 and April 6, 2020, inclusive, (the “Class Period”) of the important June 8, 2020 lead plaintiff deadline in the securities class action. The…
Leer más...